What is a Biosimilar Medicine?

September 30, 2015

The National Health Service Commissioning Board was established on 1 October 2012 as an executive non-departmental public body. Since 1 April 2013, the National Health Service Commissioning Board has used the name NHS England for operational purposes. The following organisations, listed alphabetically, have partnered with NHS England in developing this document. It should be noted that MHRA has only commented on regulatory aspects of the paper.

Spotlight

HFMA Australia

At HFMA we strive to create a sustainable healthcare for a healthy Australia. Our mission is to connect and build capacity and capability in Australian health finance professionals in order for them to become leaders in the Health Industry. Our Strategic Plan will see many progressions into the future, as we take on new events and projects to allow our member benefits to grow.

OTHER WHITEPAPERS
news image

Standard Consumer Scoring Tools Don’t Fit Patients

whitePaper | December 9, 2022

There’s no such thing as a “one size fits all” patient engagement strategy. Healthcare organization executives should beware— using conventional scoring tools to predict how patients will engage with and pay their healthcare bills is not an effective strategy.

Read More
news image

4 Tips for Licensing Your Telehealth Providers

whitePaper | May 20, 2022

Starting your own telemedicine practice or expanding your virtual care services? With the telehealth transformation underway,

Read More
news image

DEI in Health Systems: Fostering an Inclusive Environmentfor a Healthier Future

whitePaper | November 24, 2022

A Healthgrades Healthcare Marketers Survey found that 70% of marketers identified DEI as a key investment area in their 2022 marketing strategy.1

Read More
news image

G7 Health Ministers’ Communiqué

whitePaper | May 20, 2022

We, the G7 Health Ministers, met in Berlin, Germany, on 19 and 20 May 2022, at an extraordinary time of multiple, acute crises.

Read More
news image

Porter Research for Healthcare and Life Sciences

whitePaper | May 16, 2023

The healthcare and life sciences communities have been undergoing a massive digital transformation since the COVID-19 pandemic. Everything from healthcare consumer expectations to government regulations are driving providers, payers, and pharmaceutical organizations to move aggressively toward digital interactions and transactions

Read More
news image

The Path Forward: Improving Data to Advance Health EquitySolutions

whitePaper | January 4, 2023

The Centers for Medicare & Medicaid Services (CMS) relies on data to inform planning and execution of policies that affect more than 170 million individuals enrolled in CMS programs nationwide, including but not limited to Medicare, Medicaid & the Children’s Health Insurance Program (CHIP)

Read More

Spotlight

HFMA Australia

At HFMA we strive to create a sustainable healthcare for a healthy Australia. Our mission is to connect and build capacity and capability in Australian health finance professionals in order for them to become leaders in the Health Industry. Our Strategic Plan will see many progressions into the future, as we take on new events and projects to allow our member benefits to grow.

Events